WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING AND AFTER RADIATION THERAPY? - PowerPoint PPT Presentation

About This Presentation
Title:

WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING AND AFTER RADIATION THERAPY?

Description:

WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING AND AFTER RADIATION THERAPY? Bhadrasain Vikram, MD GLIOBLASTOMA Stupp, NEJM 352:987-96, 2005. Grade 3 non-heme ... – PowerPoint PPT presentation

Number of Views:59
Avg rating:3.0/5.0
Slides: 15
Provided by: rrpCancer
Learn more at: https://rrp.cancer.gov
Category:

less

Transcript and Presenter's Notes

Title: WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING AND AFTER RADIATION THERAPY?


1
WHAT ARE THE MOST SERIOUS ADVERSE EVENTS DURING
AND AFTER RADIATION THERAPY?
  • Bhadrasain Vikram, MD

2
GLIOBLASTOMAStupp, NEJM 352987-96, 2005.
  • gtGrade 3 non-heme toxicity in 31. Most common
  • Fatigue other constitutional symptoms
  • Rashes other skin effects
  • Infection
  • Effects on vision
  • Nausea Vomiting

3
HEAD NECKBonner, NEJM 354567-78, 2006.
  • gtGrade 3 toxicity
  • Mucosal 56
  • Dysphagia 26
  • Dermatitis 23
  • Weight loss 11

4
SMALL CELL LUNG - LDTurrisi, NEJM 340265-71,
1999.
  • gtGrade 3 non-heme toxicity
  • Esophagitis in 32
  • Infection
  • Fever
  • Vomiting
  • Pulmonary effects
  • Weight loss

5
ESOPHAGUSMinsky, JCO 201167-74, 2002.
  • gtGrade 3 acute toxicity in 71.
  • gtGrade 3 late toxicity in 37.
  • Esophageal strictures, perforations, bleeding.

6
BREAST POST-LUMPECTOMYFyles, NEJM 351963-970,
2004.
  • gtGrade 3 toxicity
  • Fatigue 1
  • Skin erythema 1

7
BREAST POST-MASTECTOMYRagaz, JNCI 97116-1126,
2005.
  • gtGrade 3 late toxicity _at_ 20 years
  • Cardiac 1
  • Arm edema 6
  • Symptomatic pneumonitis 0.6

8
PANCREAS POST-OPRegine, JAMA 2991019-1026,
2008.
  • gtGrade 3 non-heme toxicity in 58. Most
    common
  • Diarrhea
  • Stomatitis
  • Nausea Vomiting

9
PROSTATE LOW-RISKLawton, IJROBP 6739-47, 2007.
  • gtGrade 3 acute toxicity
  • GU bleeding/toxicity 8
  • gtGrade 3 late toxicity
  • Erectile dysfunction 9
  • GU obstruction/retention 2

10
PROSTATE HIGH-RISKBolla, Lancet 360103-108,
2002.
  • gtGrade 3 toxicity
  • Erectile dysfunction 68
  • GI/GU toxicity 3.7

11
CERVIXMorris, NEJM 3401137-1143, 1999.
  • gtGrade 3 acute non-heme toxicity in 11. Most
    common
  • Nausea vomiting
  • Diarrhea
  • gtGrade 3 late toxicity in 12. Most common
  • Bowel Urinary toxicity

12
RECTUMSauer, NEJM 3511731-1740, 2004.
  • gtGrade 3 non-heme acute toxicity in 27. Most
    common
  • Diarrhea
  • Dermatitis
  • gtGrade 3 late toxicity in 14. Most
    common
  • Diarrhea
  • Bowel obstruction/strictures
  • Bladder problems

13
ANALAjani, JAMA 2991914-1921, 2008.
  • gtGrade 3 non-heme acute toxicity in 74. Most
    common
  • Skin toxicity
  • Bowel toxicity
  • gtGrade 3 late toxicity in 11. Most
    common
  • Bowel toxicity
  • Skin Subcutaneous

14
SUMMARY
  • Serious adverse events frequently occur during
    and after radiation therapy in many common
    cancers.
  • The impact of advanced technologies (IMRT,
    Protons, etc.) in that regard has until now been
    quite modest.
Write a Comment
User Comments (0)
About PowerShow.com